ArticleMicrobiology spectrum2025
Shifts in
F Márquez-Friedrichs, M B Nolly, A Ferreyra, L Zuloaga, S Dominguez, A Secotaro, V S Rathour, M T Damiani, L Contreras, D G Sánchez
Abstract read
In one paragraphArticle in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
F Márquez-Friedrichs *Laboratorio de Bioquímica e Inmunidad, Instituto de Bioquímica y Biotecnología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
M B Nolly *Laboratorio de Bioquímica e Inmunidad, Instituto de Bioquímica y Biotecnología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.ORCID 0000-0001-6552-4209 A FerreyraLaboratorio de Bacteriología del Hospital Central, Mendoza, Argentina.
L ZuloagaLaboratorio de Bacteriología del Hospital Central, Mendoza, Argentina.
S DominguezLaboratorio de Bacteriología del Hospital Central, Mendoza, Argentina.
A SecotaroLaboratorio de Bacteriología del Hospital Central, Mendoza, Argentina.
V S RathourLaboratorio de Bioquímica e Inmunidad, Instituto de Bioquímica y Biotecnología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
M T DamianiLaboratorio de Bioquímica e Inmunidad, Instituto de Bioquímica y Biotecnología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
L ContrerasLaboratorio de Bacteriología del Hospital Central, Mendoza, Argentina.
D G Sánchez *Laboratorio de Biotecnología, Facultad de Ciencias Aplicadas a la Industria, Universidad Nacional de Cuyo (UNCuyo), San Rafael, Argentina.
Funding
Consejo Nacional de Investigaciones Científicas y Técnicas PIP 0206
6 · The paper itselfAbstract
This study analyzes the molecular epidemiology of
Indexed as
Bacteriabeta-LactamasesCOVID-19IntegronsAnti-Bacterial AgentsArgentinaDrug Resistance, Multiple, BacterialEscherichia coliHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsPrevalenceSARS-CoV-2Anti-Bacterial Agentsbeta-LactamasesClass 1 integronextended-spectrum beta-lactamases (ESBL)genes coding for ESBLsurveillance studies
Identifiers
PMID40662585
PMCPMC12323324
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390